Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry
Docket Number: FDA-2021-D-1051 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research This guidance provides recommendations to assist industry and other parties involved in the development …